The 10 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 69.50, with a high estimate of 80.00 and a low estimate of 31.00. The median estimate represents a +20.81% increase from the last price of 57.53.
The current consensus among 10 polled investment analysts is to Buy stock in Arcturus Therapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.54
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.